Gene | OMIM Diseases | Inheritance* | % Gene Coverage (20x) | HGMD** |
AARS1 | Charcot-Marie-Tooth Disease, Epileptic Encephalopathy | AD,AR | 99.07 | 30 of 30 |
ABAT | Gaba-Transaminase Deficiency | AR | 100 | 9 of 9 |
ABCA2 | Intellectual Developmental Disorder, Seizures, Ataxia | AR | 99.05 | 11 of 11 |
ABCC8 | Diabetes Mellitus, Hyperinsulinemic Hypoglycemia, Dend Syndrome | AD,AR | 99.98 | 710 of 712 |
ABCD1 | Adrenoleukodystrophy | X,XR,G | 100 | – |
ACTL6B | Epileptic Encephalopathy, Intellectual Developmental Disorder | AD,AR | 100 | 21 of 21 |
ACY1 | Aminoacylase 1 Deficiency | AR | 100 | 15 of 15 |
ADAM22 | Epileptic Encephalopathy | AR | 99.98 | 4 of 4 |
ADAR | Aicardi-GoutieresSyndrome, DyschromatosisSymmetrica, Bilateral Striatal Necrosis | AD,AR | 99.93 | 252 of 252 |
ADGRG1 | Polymicrogyria | AR | 100 | – |
ADGRV1 | Febrile Convulsions, Usher Syndrome, Epilepsy | AD,AR | 97.53 | – |
ADPRS | Neurodegeneration, Ataxia | AR | 99.86 | 11 of 11 |
ADRA2B | Epilepsy | – | 100 | 5 of 5 |
ADSL | Adenylosuccinate LyaseDeficiency | AR | 100 | 59 of 59 |
AFG3L2 | OpticAtrophy, Ataxia, Epilepsy | AD,AR | 99.74 | 42 of 42 |
AGA | Aspartylglucosaminuria | AR | 100 | 35 of 35 |
AHI1 | Joubert Syndrome, Retinitis Pigmentosa | AR | 96.79 | 85 of 97 |
AIFM1 | Oxidative Phosphorylation Deficiency, Cowchock Syndrome, Deafness, Spondyloepimetaphyseal Dysplasia, Leukoencephalopathy, Mitochondrial Encephalomyopathy, Charcot-Marie-Tooth Disease | X,XR,G | 100 | – |
AIMP1 | Leukodystrophy, IntellectualDisability | AR | 100 | 10 of 10 |
AKT3 | Megalencephaly- Polymicrogyria- Postaxial Polydactyly- Hydrocephalus Syndrome | AD | 99.9 | 9 of 11 |
ALDH3A2 | Sjogren-Larsson Syndrome | AR | 96 | 119 of 119 |
ALDH4A1 | Hyperprolinemia | AR | 100 | 7 of 7 |
ALDH5A1 | SuccinicSemialdehyde Dehydrogenase Deficiency | AR | 95.41 | 65 of 69 |
ALDH7A1 | Epilepsy | AR | 99.98 | 131 of 134 |
ALG1 | CongenitalDisorder Of Glycosylation | AR | 100 | 46 of 46 |
ALG12 | CongenitalDisorder Of Glycosylation | AR | 100 | 17 of 17 |
ALG13 | EpilepticEncephalopathy, IntellectualDisability | X,XR,XD,G | 99.62 | – |
ALG2 | Congenital Disorder Of Glycosylation, Myasthenic Syndrome | AR | 99.61 | 7 of 7 |
ALG3 | CongenitalDisorder Of Glycosylation | AR | 99.2 | 25 of 25 |
ALG6 | CongenitalDisorder Of Glycosylation | AR | 99.91 | 24 of 24 |
ALG8 | Congenital Disorder Of Glycosylation, Polycystic Liver Disease | AD,AR | 99.5 | 22 of 22 |
ALG9 | Congenital Disorder Of Glycosylation, Polycystic Kidney Disease, Microbrachycephaly, Hypertelorism | AR | 99.99 | 6 of 6 |
ALKBH8 | IntellectualDevelopmental Disorder | AR | 99.2 | 2 of 2 |
AMACR | Alpha-Methylacyl-Coa Racemase Deficiency | AR | 100 | 8 of 8 |
AMT | GlycineEncephalopathy | AR | 99.98 | 94 of 96 |
ANK3 | Mental Retardation | AR | 99.76 | 22 of 23 |
ANKRD11 | Kbg Syndrome, 16q24.3 Microdeletion Syndrome | AD | 99.6 | 119 of 124 |
AP2M1 | Intellectual Developmental Disorder, Myoclonic Astastic Epilepsy | AD | 100 | 1 of 1 |
AP3B2 | EpilepticEncephalopathy | AR | 99.95 | 11 of 12 |
AP4B1 | SpasticParaplegia, IntellectualDisability | AR | 99.64 | 22 of 22 |
AP4E1 | Spastic Paraplegia, Stuttering, Severe Intellectual Disability | AD,AR | 99.94 | 17 of 17 |
AP4M1 | Spastic Paraplegia, Severe Intellectual Disability | AR | 100 | 18 of 18 |
AP4S1 | Spastic Paraplegia, Severe Intellectual Disability | AR | 99.95 | 8 of 8 |
ARFGEF2 | Microcephaly, Periventricular Nodular Heterotopia | AR | 100 | 15 of 15 |
ARG1 | Argininemia | AR | 100 | 66 of 68 |
ARHGEF15 | Angelman Syndrome, Epileptic Encephalopathy, Spastic Ataxia | – | 99.89 | 3 of 3 |
ARHGEF9 | Hyperekplexia, Epilepsy | X,XR,G | 100 | – |
ARID1B | Coffin-Siris Syndrome, 6q25 Microdeletion Syndrome | AD | 93.87 | 226 of 238 |
ARL13B | Joubert Syndrome | AR | 99.77 | 10 of 10 |
ARSA | Metachromatic Leukodystrophy | AR | 98 | 266 of 266 |
ARSB | Mucopolysaccharidosis | AR | 99.83 | 217 of 220 |
ARV1 | EpilepticEncephalopathy | AR | 100 | 3 of 3 |
ARX | Corpus Callosum, Epileptic Encephalopathy, Lissencephaly, Mental Retardation, Partington Syndrome, West Syndrome | X,XR,G | 81.92 | – |
ASAH1 | Farber Lipogranulomatosis, Spinal Muscular Atrophy, MyoclonicEpilepsy | AR | 99.98 | 69 of 70 |
ASNS | AsparagineSynthetase Deficiency | AR | 99.98 | 37 of 37 |
ASPA | CanavanDisease | AR | 99.56 | 93 of 94 |
ASPM | Microcephaly | AR | 99.74 | 221 of 222 |
ASXL3 | Bainbridge-Ropers Syndrome, Feeding Difficulties, Failure To Thrive, Microcephaly | AD | | 77 of 81 |
ATAD1 | Hyperekplexia | AR | 99.97 | 3 of 3 |
ATIC | Imp Cyclohydrolase, Charcot Marie Tooth Disease | AR | 98.77 | 8 of 8 |
ATN1 | CongenitalHypotonia, Chorea, Seizures, Dementia, Dentatorubral Pallidoluysian Atrophy | AD | 99.86 | 11 of 11 |
ATP13A2 | Kufor-Rakeb Syndrome, Spastic Paraplegia, Ceroid Lipofuscinosis | AR | 99.97 | 53 of 53 |
ATP1A2 | Alternating Hemiplegia Of Childhood, Migraine | AD | 100 | 108 of 108 |
ATP1A3 | Alternating Hemiplegia Of Childhood, Cerebellar Ataxia, Optic Atrophy, Sensorineuralhearing Loss, Dystonia, Areflexia, Pes Cavus, Parkinsonism | AD | 99.94 | 138 of 138 |
ATP2A2 | AcrokeratosisVerruciformis, Darier-White Disease | AD | 100 | 298 of 301 |
ATP6AP2 | Congenital Disorder Of Glycosylation, Mental Retardation, Epilepsy, Parkinsonism | X,XR,G | 100 | – |
ATP6V0A2 | Cutis Laxa, Wrinkly Skin Syndrome | AR | 99.99 | 55 of 55 |
ATP6V1A | Cutis Laxa, Epileptic Encephalopathy | AD,AR | 99.98 | 9 of 9 |
ATP7A | Cutis Laxa, Menkes Disease, Spinal Muscular Atrophy, Occipital HornSyndrome | X,XR,G | 99.83 | – |
ATPAF2 | AtpaseDeficiency | AR | 100 | 2 of 2 |
ATRX | Alpha-Thalassemia MyelodysplasiaSyndrome, Mental Retardation- Hypotonic Facies Syndrome , Carpenter-Waziri Syndrome, Chudley-Lowry-Hoar Syndrome, Holmes- GangSyndrome, Juberg- MarsidiSyndrome, Smith- Fineman-Myers Syndrome | X,XR,XD,G | 98.5 | – |
AUH | 3-Methylglutaconic Aciduria | AR | 99.99 | 11 of 11 |
B4GALT1 | CongenitalDisorder Of Glycosylation | AR | 99.97 | 3 of 3 |
BCKDK | Branched-Chain Ketoacid Dehydrogenase Kinase Deficiency | – | 99.91 | 6 of 6 |
BCS1L | BjornstadSyndrome, GracileSyndrome, Leigh Syndrome, MitochondrialComplex IIIDeficiency | AR,MI | 99.96 | 40 of 42 |
BOLA3 | Mitochondrial Dysfunctions Syndrome | AR | 100 | 8 of 8 |
BRAF | Cardiofaciocutaneous Syndrome, Leopard Syndrome, Lung Cancer, Craniopharyngioma, Noonan Syndrome | AD | 100 | 80 of 80 |
BRAT1 | Neurodevelopmental Disorder, Cerebellar Atrophy, Rigidity And Multifocal Seizure Syndrome | AR | 99.95 | 29 of 29 |
BRD2 | Photosensitive Epilepsy | – | 92.11 | 1 of 1 |
BTD | Biotinidase Deficiencymultiple Carboxylase Deficiency | AR | 100 | 261 of 262 |
BUB1B | Colorectal Cancer, Mosaic Variegated Aneuploidy Syndrome | AD,AR | 99.84 | 30 of 31 |
C12ORF57 | Craniofacial Dysmorphism, Ocular Coloboma, Temtamy Syndrome | AR | – | – |
CACNA1A | Epileptic Encephalopathy, Ataxia, Migraine, Benign Paroxysmal Torticollis Of Infancy | AD | 96.13 | 249 of 266 |
CACNA1B | Neurodevelopmental Disorder, Seizures, Hyperkinetic Movements, Epileptic Encephalopathy | AR | 95.83 | 7 of 7 |
CACNA1D | Primary Aldosteronism, Seizures, Neurologic Abnormalities, Sinoatrial Node Dysfunction, Deafness | AD,AR | 100 | 18 of 18 |
CACNA1E | Epileptic Encephalopathy | AD | 99.94 | 25 of 25 |
CACNA1H | Hyperaldosteronism, Epilepsy | AD | 98.05 | 71 of 71 |
CACNA2D2 | CerebellarAtrophy, Seizures, DevelopmentalDelay | AR | 94 | 10 of 10 |
CACNB4 | Epilepsy, Ataxia | AD | 99.87 | 5 of 5 |
CAD | Epileptic Encephalopathy | AR | 100 | 12 of 12 |
CARS2 | Oxidative Phosphorylation Deficiency | AR | 99.14 | 6 of 6 |
CASK | Anemia, Fg Syndrome, Mental Retardation, Microcephaly, Pontine And Cerebellar Hypoplasia, Epileptic Encephalopathy | X,XR,XD,G | 99.98 | – |
CASR | Hyperparathyroidism, Hypocalcemia, Pancreatitis | AD,AR | 100 | 445 of 446 |
CBL | Myelomonocytic Leukemia, Noonan Syndrome, Mastocytosis, Noonan Syndrome | AD | 100 | 46 of 47 |
CC2D1A | Mental Retardation | AR | 100 | 7 of 7 |
CC2D2A | Coach Syndrome, Joubert Syndrome, Meckel Syndrome | AR | 99.43 | 98 of 100 |
CCDC88C | Hydrocephalus, Spinocerebellar Ataxia | AD,AR | 99.44 | 13 of 14 |
CCL2 | Neural TubeDefects | AD | 100 | – |
CDK9 | Inmune Deficiency Disease, Myeloma | – | 82.69 | 2 of 2 |
CDKL5 | Epileptic Encephalopathy, Atypical Rett Syndrome, West Syndrome | X,XD,G | 99.92 | – |
CENPJ | Microcephaly, SeckelSyndrome | AR | 99.97 | 13 of 13 |
CEP290 | Bardet-Biedl Syndrome, Joubert Syndrome, Leber Congenital Amaurosis, Meckel Syndrome, Senior- Loken Syndrome | AR | 96.47 | 293 of 327 |
CERS1 | Epilepsy | AR | 72.1 | 2 of 2 |
CERT1 | Mental Retardation | AD | 99.98 | 8 of 8 |
CHD2 | Epileptic Encephalopathy, Lennox-Gastaut Syndrome | AD | 98.91 | 103 of 103 |
CHRNA2 | Epilepsy | AD | 99.91 | 8 of 8 |
CHRNA4 | Epilepsy | AD | 99.8 | 24 of 24 |
CHRNB2 | Epilepsy | AD | 100 | 13 of 13 |
CILK1 | Endocrine- Cerebroo- steodysplasia, Epilepsy | AD,AR | 100 | – |
CLCN2 | Epilepsy, Hyperaldosteronism, Leukoencephalopathy | AD,AR | 100 | 39 of 39 |
CLCN4 | Mental Retardation | X,XR,XD,G | 99.69 | – |
CLN3 | CeroidLipofuscinosis | AR | 99.93 | 73 of 75 |
CLN5 | CeroidLipofuscinosis | AR | 99.56 | 52 of 55 |
CLN6 | CeroidLipofuscinosis | AR | 99.94 | 98 of 99 |
CLN8 | CeroidLipofuscinosis, IntellectualDisability | AR | 100 | 44 of 45 |
CLTC | Mental Retardation, Epileptic Encephalopathy | AD | 98.81 | 14 of 14 |
CNKSR2 | Mental Retardation, Epileptic Encephalopathy | X,G | 99.11 | – |
CNPY3 | Epileptic Encephalopathy, West Syndrome | AR | 100 | 5 of 5 |
CNTN2 | Epilepsy | AR | 99.98 | 6 of 6 |
CNTNAP2 | Pitt-Hopkins- LikeSyndrome | AR | 99.91 | 39 of 41 |
COA7 | Spinocerebellar Ataxia | AR | 99.99 | 6 of 6 |
COA8 | MitochondrialComplexIv Deficiency, Leukoencephalopathy | AR,MI | 86.26 | 4 of 5 |
COG7 | CongenitalDisorder Of Glycosylation | AR | 99.94 | 6 of 6 |
COG8 | CongenitalDisorder Of Glycosylation | AR | 100 | 8 of 8 |
COL18A1 | Glaucoma, KnoblochSyndrome | AD,AR | 99.76 | – |
COL4A1 | Angiopathy, Microangiopathy, Leukoencephalopathy, Porencephaly, Retinal Arteries, Hanac Syndrome, Walker-Warburg Syndrome | AD | 99.99 | 173 of 173 |
COQ2 | Coenzyme Q10 Deficiency, Multiple System Atrophy, Leigh Syndrome, Nephrotic Syndrome | AD,AR | 99.61 | 37 of 38 |
COQ4 | Coenzyme Q10 Deficiency | AR | 91.05 | 21 of 21 |
COQ8A | Coenzyme Q10 Deficiency, Ataxia | AR | 100 | – |
COQ9 | Coenzyme Q10 Deficiency | AR | 99.87 | 6 of 6 |
COX10 | Leigh Syndrome, Mitochondrial Complex Iv Deficiency | AR,MI | 100 | 13 of 13 |
COX15 | Cardioence phalomyopathy, Leigh Syndrome, Leukodystrophy | AR,MI | 100 | 5 of 5 |
COX6B1 | Mitochondrial ComplexIv Deficiency | AR,MI | 100 | 3 of 3 |
CPA6 | Epilepsy, FebrileSeizures | AD,AR | 99.97 | 9 of 9 |
CPLX1 | Epileptic Encephalopathy, Wolf-Hirschhorn Syndrome | AD,AR | 99.81 | 3 of 3 |
CPT2 | Carnitine PalmitoyltransferaseIi Deficiency, Encephalopathy | AD,AR | 99.99 | 116 of 116 |
CRH | Epilepsy, Conn Syndrome, Depression | – | 99.84 | 1 of 2 |
CSF1R | BrainAbnormalities, Gliosis | AD,AR | 100 | 122 of 124 |
CSNK2B | Poirier- Bienvenu Neurodevelopmental Syndrome | AD | 99.98 | 14 of 17 |
CSTB | Epilepsy, Hypohidrotic Ectodermal Dysplasia, Unverricht-Lundborg Disease | AR | 100 | 14 of 14 |
CTC1 | Cerebroretinal Microangiopathy, DyskeratosisCongenita | AR | 99.73 | 43 of 44 |
CTNND2 | Benign Adult Familial Myoclonic Epilepsy | – | 94.3 | 10 of 12 |
CTSA | Neuraminidase Deficiency, Galactosialidosis | AR | 100 | 40 of 40 |
CTSD | CeroidLipofuscinosis | AR | 100 | 18 of 18 |
CTSF | CeroidLipofuscinosis | AR | 92.18 | 12 of 12 |
CUL4B | Mental Retardation, Short Stature, Musclewasting | X,XR,G | 99.77 | – |
CUX2 | Epileptic Encephalopathy, Lennox-Gastaut Syndrome | AD | 99.72 | 2 of 2 |
CYFIP2 | Epileptic Encephalopathy | AD | 100 | 8 of 8 |
CYP27A1 | Cerebrotendinous Xanthomatosis | AR | 100 | 118 of 118 |
D2HGDH | D-2-Hydroxyglutaric Aciduria | AR | 100 | 42 of 42 |
DARS1 | Hypomyelination | AR | 99.99 | 18 of 18 |
DARS2 | Leuko encephalopathy | AR | 100 | 65 of 65 |
DCX | Lissencephaly | X,G | 100 | – |
DDC | Amino Acid Decarboxylase Deficiency | AR | 100 | 59 of 59 |
DDX3X | Intellectual Developmental Disorder | X,XR,XD,G | 99.03 | – |
DEAF1 | Dyskinesia, Seizures, Intellectual Developmental Disorder, Smith- Magenis Syndrome | AD,AR | 93.55 | 42 of 42 |
DEGS1 | Leukodystrophy | AR | 86.16 | 12 of 14 |
DENND5A | Epileptic Encephalopathy | AR | 100 | 9 of 9 |
DEPDC5 | Epilepsy | AD | 100 | 127 of 127 |
DHCR7 | Smith-Lemli- OpitzSyndrome | AR | 100 | 217 of 217 |
DHDDS | Developmental Delay, Seizures, Retinitis Pigmentosa, Epileptic Encephalopathy | AD,AR | 96.32 | 8 of 8 |
DHFR | Megaloblastic Anemia, Dihydrofolate Reductase Deficiency | AR | 99.7 | 4 of 4 |
DHPS | Neurodevelopmenta Disorder, Seizures | AR | 99.85 | 4 of 4 |
DIAPH1 | Deafness, Seizures | AD,AR | 99.94 | 15 of 15 |
DLD | Pyruvate Dehydrogenase Deficiency | AR | 100 | 26 of 26 |
DNAJC5 | Ceroid Lipofuscinosis | AD | 100 | 2 of 2 |
DNM1 | Epileptic Encephalopathy, Lennox-Gastaut Syndrome | AD | 94.8 | 30 of 30 |
DNM1L | Encephalopathy, OpticAtrophy | AD,AR | 100 | 29 of 29 |
DOCK7 | EpilepticEncephalopathy, Cortical Blindness | AR | 99.95 | 11 of 11 |
DOLK | Congenital Disorder Of Glycosylation, Dilated Cardiomyopathy | AR | 99.98 | 13 of 13 |
DPAGT1 | Congenital Disorder Of Glycosylation, Myasthenic Syndrome | AR | 100 | 41 of 41 |
DPM1 | CongenitalDisorder Of Glycosylation | AR | 97.25 | 9 of 9 |
DPM2 | Congenital Disorder Of Glycosylation, Muscular Dystrophy, Intellectual Disability, Epilepsy | AR | 99.87 | 2 of 2 |
DPYD | Dihydropyrimidine Dehydrogenase Deficiency, 1p21.3 MicrodeletionSyndrome | AR | 100 | 74 of 75 |
DPYS | Dihydropyrimidinuria | AR | 100 | 31 of 31 |
DYNC1H1 | Charcot-Marie-Tooth Disease, Mental Retardation, Spinal Muscular Atrophy | AD | 100 | 104 of 104 |
DYRK1A | Mental Retardation | AD | 99.85 | 78 of 81 |
EARS2 | Oxidative Phosphorylation Deficiency | AR | 98.8 | 31 of 31 |
ECHS1 | Mitochondrial Short-Chain Enoyl-Coa Hydratase 1 Deficiency, Leigh Syndrome, Leukodystrophy | AR | 100 | 39 of 39 |
ECM1 | LipoidProteinosis | AR | 99.99 | 64 of 64 |
EEF1A2 | EpilepticEncephalopathy, Mental Retardation | AD | 100 | 14 of 14 |
EFHC1 | Epilepsy | AD | 100 | 38 of 39 |
EHMT1 | KleefstraSyndrome | AD | 98.58 | 58 of 75 |
EIF2B1 | Leukoencephalopathy, Vanishing White Matter | AR | 100 | 9 of 9 |
EIF2B2 | Leukoencephalopathy, Vanishing White Matter | AR | 100 | 30 of 30 |
EIF2B3 | Leukoencephalopathy, Vanishing White Matter | AR | 97.55 | 26 of 26 |
EIF2B4 | Leukoencephalopathy, Vanishing White Matter | AR | 100 | 31 of 31 |
EIF2B5 | Leukoencephalopathy, Vanishing White Matter | AR | 100 | 99 of 99 |
EIF3F | Intellectual Developmental Disorder | AR | 99.99 | 1 of 1 |
EMX2 | Schizencephaly | – | 100 | 5 of 5 |
EPM2A | LaforaDisease | AR | 89.2 | 63 of 70 |
EPRS1 | Leukodystrophy | AR | 99.62 | 6 of 6 |
ETFA | Acyl-Coa Dehydrogenase Deficiency | AR | 92.33 | 32 of 32 |
ETFB | Acyl-Coa Dehydrogenase Deficiency | AR | 100 | 21 of 21 |
ETFDH | Acyl-Coa Dehydrogenase Deficiency | AR | 100 | 221 of 222 |
ETHE1 | Encephalopathy | AR | 100 | 32 of 33 |
FA2H | Spastic Paraplegia, Fatty Acid Hydroxylase- Associated Neurodegeneration | AR | 88.77 | 60 of 62 |
FAM126A | Hypomyelination, CongenitalCataract | AR | 100 | 11 of 12 |
FAR1 | Fatty Acyl-Coa Reductase 1 Deficiency | AR | 98.77 | 4 of 4 |
FARS2 | Oxidative Phosphorylation Deficiency, Spastic Paraplegia | AR | 99.98 | 23 of 23 |
FASN | FattyLiverDisease | – | 100 | 6 of 6 |
FCSK | CongenitalDisorder Of Glycosylation | AR | 97.99 | – |
FDFT1 | SqualeneSynthase Deficiency | AR | 99.77 | 3 of 4 |
FDX2 | MitochondrialMyopathy, Leukoencephalopathy | AR,MI | 100 | – |
FGD1 | Aarskog-Scott Syndrome | X,XR,G | 98.95 | – |
FGF12 | EpilepticEncephalopathy | AD | 99.98 | 4 of 6 |
FGFR3 | Achondroplasia, Hypochondroplasia, Camptodactyly, CrouzonSyndrome, Epidermal Nevus, Lacrimoauricul odentodigital Syndrome, MuenkeSyndrome, Thanatophoric Dysplasia, IsolatedBrachycephaly, IsolatedPlagiocephaly, Saethre-Chotzen Syndrome | AD,AR | 99.89 | 77 of 78 |
FH | FumaraseDeficiency, Leiomyomatosis | AD,AR | 100 | 229 of 232 |
FKRP | Dystroglycanopathy, Limb-Girdle Muscular Dystrophy, Muscle- Eye-Brain Disease, Walker-Warburg Syndrome | AR | 99.9 | 157 of 157 |
FKTN | Cardiomyopathy, Dystroglycanopathy, Limb-Girdle Muscular Dystrophy, Muscle- Eye-Brain Disease, Walker-Warburg Syndrome | AR | 98 | 54 of 56 |
FLNA | Cardiac Valvular Dysplasia, FgSyndrome, Frontometaphyseal Dysplasia, Heterotopia, Intestinal Pseudoobstruction, Melnick-NeedlesSyndrome, OtopalatodigitalSyndrome, Terminal OsseousDysplasia, Short BowelSyndrome, Ehlers-Danlos Syndrome | X,XR,XD,G | 100 | – |
FOLR1 | Neurodegeneration | AR | 100 | 19 of 23 |
FOXG1 | Rett Syndrome, 14q12 Microdeletion Syndrome | AD | 88.71 | 93 of 109 |
FOXRED1 | Mitochondrial Complex I Deficiency, Leigh Syndrome, Leukodystrophy | AR | 100 | 13 of 13 |
FRRS1L | EpilepticEncephalopathy, IntellectualDisability | AR | 85.58 | 7 of 7 |
FUCA1 | Fucosidosis | AR | 100 | 31 of 32 |
FUT8 | Congenital Disorder Of Glycosylation, Fucosylation | AR | 99.73 | 4 of 4 |
GABBR2 | Epileptic Encephalopathy, Neurodevelopmental Disorder, Rett Syndrome | AD | 95.98 | 7 of 7 |
GABRA1 | EpilepticEncephalopathy, DravetSyndrome | AD | 100 | 45 of 46 |
GABRA2 | Alcohol Dependence, Epileptic Encephalopathy | AD,MU | 99.08 | 3 of 3 |
GABRA3 | ThyrotoxicPeriodic Paralysis | – | 99.91 | – |
GABRA5 | Epileptic Encephalopathy | AD | 99.94 | 9 of 9 |
GABRB1 | Epileptic Encephalopathy | AD | 99.98 | 9 of 9 |
GABRB2 | Epileptic Encephalopathy | AD | 99.19 | 16 of 19 |
GABRB3 | EpilepticEncephalopathy, Lennox-Gastaut Syndrome | AD | 100 | 54 of 62 |
GABRD | Epilepsy, 1p36 DeletionSyndrome | AD | | 3 of 3 |
GABRG2 | EpilepticEncephalopathy, DravetSyndrome | AD | 99.67 | 53 of 53 |
GAL | Epilepsy | AD | 100 | 1 of 1 |
GALC | KrabbeDisease | AR | 99.38 | 252 of 254 |
GAMT | Cerebral Creatine DeficiencySyndrome, Guanidinoacetate Methyltransferase Deficiency | AR | 99.92 | 60 of 60 |
GATM | Cerebral Creatine Deficiency Syndrome , Fanconi Renotubular Syndrome | AD,AR | 99.98 | 21 of 21 |
GCDH | Glutaric Acidemia, Glutaryl-Coa Dehydrogenase Deficiency | AR | 88.74 | 254 of 254 |
GCH1 | Dystonia, GtpCyclohydrolase I Deficiency | AD,AR | 99.41 | 225 of 244 |
GCSH | Glycine Encephalopathy | AR | 93.52 | 1 of 1 |
GFAP | Alexander Disease | AD | 99.98 | 143 of 143 |
GFM1 | CombinedOxidative Phosphorylation Deficiency | AR | 100 | 27 of 27 |
GFM2 | CombinedOxidative Phosphorylation Deficiency | AR | 99.35 | 5 of 7 |
GJC2 | Leukodystrophy, Lymphedema, Spastic Paraplegia, Milroy Disease | AD,AR | 95.37 | 52 of 63 |
GLB1 | Gangliosidosis, Morquio Syndrome | AR | 100 | 242 of 243 |
GLDC | Glycine Encephalopathy | AR | 98.69 | 359 of 367 |
GLI2 | Holoprosencephaly, Pallister-Hall Syndrome, Pituitary Hormone Deficiencies | AD | 98.38 | 83 of 88 |
GLI3 | GreigCephalopolysyndactyly Syndrome, Hypothalamic Hamartomascongenital Hypothalamic HamartomaSyndrome, Pallister-Hall Syndrome, AcrocallosalSyndrome, Tibial Hemimelia | AD,AR | 100 | 231 of 231 |
GLRA1 | Hyperekplexia | AD,AR | 99.6 | 71 of 72 |
GLRB | Hyperekplexia | AR | 99.3 | 16 of 18 |
GLS | Epileptic Encephalopathy, Global Developmental Delay, Infantile Cataract | AD,AR | 97.77 | 8 of 9 |
GLUD1 | Hyperinsulinemic Hypoglycemia, Hyperinsulinism- Hyperammonemia Syndrome | AD | 99.98 | 39 of 39 |
GNAO1 | EpilepticEncephalopathy, Neurodevelopmental Disorder | AD | 100 | 47 of 47 |
GNB1 | Leukemia, Mental Retardation, Global Developmental Delay | AD,MU,P | 100 | 31 of 31 |
GNE | Nonaka Myopathy, Sialuria | AD,AR | 99.97 | 248 of 253 |
GNS | Mucopoly saccharidosis | AR | 99.92 | 22 of 22 |
GOLGA2 | Vohwinkel Syndrome, Smith-Mccort Dysplasia | – | 99.89 | 3 of 3 |
GOSR2 | Epilepsy | AR | 88.39 | 6 of 6 |
GPAA1 | Glycosylphosphatidylinositol Biosynthesis Defect, Neurodevelopmental Delay | AR | 99.98 | 11 of 11 |
GPC3 | Simpson-Golabi-Behmel Syndrome, Wilms Tumor Nephroblastoma | AD,X,XR,G | 99.84 | – |
GPHN | Hyperekplexia, Molybdenum Cofactor Deficiency | AD,AR | 99.2 | 6 of 6 |
GRIA3 | Mental Retardation | X,XR,G | 98.39 | – |
GRIA4 | Neurodevelopmental Disorder | AD | 99.94 | 5 of 5 |
GRIK2 | Mental Retardation | AR | 96.98 | 5 of 6 |
GRIN1 | Neurodevelopmental Disorder | AD,AR | 100 | 43 of 43 |
GRIN2A | Epileptic Encephalopathy | AD | 100 | 143 of 143 |
GRIN2B | Epileptic Encephalopathy, Mental Retardation, West Syndrome | AD | 99.99 | 108 of 108 |
GRIN2D | Epileptic Encephalopathy | AD | 79.74 | 17 of 18 |
GRN | CeroidLipofuscinosis, Frontotemporal Lobar Degeneration, SemanticDementia | AD,AR | 100 | 220 of 229 |
GTPBP3 | Oxidative Phosphorylation Deficiency | AR | 99.94 | 17 of 17 |
GUF1 | Epileptic Encephalopathy, West Syndrome | AR | 99.88 | 4 of 4 |
HACE1 | Neuroblastoma, Spastic Paraplegia, Developmental Delay, Epilepsy | AR | 100 | 15 of 15 |
HCN1 | Epileptic Encephalopathy | AD | 98.43 | 42 of 43 |
HCN2 | Epilepsy, Retinitis Pigmentosa | – | 70.45 | 6 of 9 |
HCN4 | Brugada Syndrome, SickSinusSyndrome | AD | 98.01 | 40 of 41 |
HDAC4 | 2q37 Microdeletion Syndrome | – | 100 | 10 of 10 |
HECW2 | Neurodevelopmental Disorder, Hypotonia, Seizures | AD | 99.85 | 13 of 13 |
HEPACAM | Megalencephalic Leukoencephalopathy | AD,AR | 97.87 | 30 of 30 |
HEXA | Tay-Sachs Disease | AR | 100 | 205 of 206 |
HEXB | Sandhoff Disease | AR | 99.92 | 109 of 115 |
HGSNAT | Mucopolysaccharidosis, Retinitis Pigmentosa | AR | 87.91 | 69 of 73 |
HIBCH | 3-Hydroxyisobutyryl-Coa HydrolaseDeficiency, Neurodegeneration | AR | 96.47 | 27 of 27 |
HNRNPU | EpilepticEncephalopathy, 1q44 Microdeletion Syndrome | AD | 99.8 | 36 of 36 |
HPD | Hawkinsinuria , Tyrosinemia | AD,AR | 100 | 10 of 10 |
HRAS | Bladder Cancer, Costello Syndrome, Epidermal Nevus, Giant Pigmented Hairy Nevus, Schimmelpenning- Feuerstein-Mims Syndrome, Linear Nevus Sebaceus Syndrome | AD | 100 | 34 of 34 |
HSD17B10 | Hydroxyacyl-Coa DehydrogenaseIi Deficiency | X,XD,G | 100 | – |
HSD17B4 | D-Bifunctional Protein Deficiency, Perrault Syndrome | AR | 99.52 | 85 of 85 |
HSPD1 | Leukodystrophy SpasticParaplegia | AD,AR | 100 | 7 of 7 |
HTRA1 | Cerebral Arteriopathy, Leukoencephalopathy | AD,AR | 87.47 | 55 of 57 |
HTT | Huntington Disease, Lopes-Maciel-Rodan Syndrome | AD,AR | 99 | – |
IBA57 | Multiple Mitochondrial Dysfunctions Syndrome, Spastic Paraplegia | AR | 93.35 | 25 of 27 |
IDH2 | D-2-Hydroxyglutaric Aciduria, Maffucci Syndrome, Ollier Disease | AD | 99.99 | 4 of 4 |
IDS | Mucopolysaccharidosis | X,XR,G | 99.86 | – |
IER3IP1 | Microcephaly, Epilepsy | AR | 99.97 | 5 of 5 |
IQSEC2 | Mental Retardation, Microduplication Xp11.22p11.23 Syndrome, Smith- Magenis Syndrome | X,XR,XD,G | 99.73 | – |
IRF2BPL | Neurodevelopmental Disorder, Seizures | AD | 95.01 | 24 of 25 |
ITPA | Epileptic Encephalopathy | AR | 100 | 5 of 6 |
JMJD1C | 22q11.2 Deletion Syndrome | – | 99.09 | 27 of 27 |
JRK | Epilepsy | – | – | – |
KANSL1 | Koolen-De Vries Syndrome | AD | 96.03 | 22 of 27 |
KCNA1 | Ataxia, Epileptic Encephalopathy, Continuous Muscle Fiber Activity, Paroxysmal Kinesigenic Dyskinesia | AD | 100 | 49 of 49 |
KCNA2 | Epileptic Encephalopathy | AD | 99.86 | 23 of 23 |
KCNAB2 | 1p36 Deletion Syndrome | – | 79 | 3 of 3 |
KCNB1 | Epileptic Encephalopathy | AD | 99.95 | 55 of 55 |
KCNC1 | Epilepsy | AD | 99.87 | 10 of 10 |
KCND2 | Autism, Epileptic Encephalopathy | – | 100 | 4 of 4 |
KCNH1 | Temple-Baraitser Syndrome, Zimmermann-Laband Syndrome | AD | 99.69 | 15 of 15 |
KCNH2 | Long Qt Syndrome, Short Qt Syndrome, Romano-Ward Syndrome | AD | 98.69 | 908 of 930 |
KCNH5 | Epileptic Encephalopathy, Neuropathy | – | 98.72 | 1 of 1 |
KCNJ10 | Enlarged Vestibular Aqueduct, Pendred Syndrome, Seizures, East Syndrome | AR | 93.53 | 27 of 32 |
KCNJ11 | Diabetes Mellitus, Hyperinsulinemic Hypoglycemia, Maturity-Onset Diabetes Of The Young, Hyperinsulinism, Dend Syndrome | AD,AR | 100 | 190 of 191 |
KCNK4 | Facial Dysmorphism, Epilepsy, Gingival Overgrowth | AD | 94.93 | 2 of 2 |
KCNMA1 | Cerebellar Atrophy, Epilepsy, Paroxysmal Dyskinesia, Liang-Wang Syndrome | AD,AR | 99.98 | 24 of 26 |
KCNQ2 | Epileptic Encephalopathy | AD | 99.94 | 333 of 334 |
KCNQ3 | Epilepsy | AD | 97.94 | 40 of 40 |
KCNQ5 | Mental Retardation | AD | 95.08 | 8 of 8 |
KCNT1 | Epileptic Encephalopathy | AD | 95.98 | 64 of 64 |
KCNT2 | Epileptic Encephalopathy | AD | 98.26 | 4 of 4 |
KCNV2 | Retinal ConeDystrophy | AR | 99.98 | 86 of 88 |
KCTD3 | Variegate Porphyria , Niemann- Pick Disease | – | 96.19 | 2 of 2 |
KCTD7 | Epilepsy | AR | 99.99 | 40 of 40 |
KDM5C | Mental Retardation | X,XR,G | 100 | – |
KDM6A | Kabuki Syndrome | AD,X,XD,G | 99.98 | – |
KIF1A | Mental Retardation, Neuropathy, Spastic Paraplegia, Peho Syndrome | AD,AR | 100 | 76 of 76 |
KIFBP | Goldberg- ShprintzenSyndrome | AR | 99.27 | – |
KMT2D | Kabuki Syndrome | AD | 99.71 | 839 of 847 |
KMT2E | O’donnell-Luria- Rodan Syndrome, Intellectual Disability | AD | 99.83 | 34 of 34 |
KPNA7 | CerebellarMalformation, Cerebellar Vermis Hypoplasia | – | 100 | 3 of 3 |
KRAS | Aplasia Cutis Congenita, Cardiofaciocutaneous Syndrome, Leukemia, Noonan Syndrome, Autoimmune Lymphoproliferative Syndrome, Schimmelpenning- Feuerstein-MimsSyndrome, Encephalocraniocutaneous Lipomatosis, Linear Nevus SebaceusSyndrome, Lynch Syndrome, Toriello-Lacassie- DrosteSyndrome | AD | 100 | 38 of 38 |
L2HGDH | L-2-Hydroxyglutaric Aciduria | AR | 100 | 72 of 73 |
LAMA2 | Limb-Girdle Muscular Dystrophy | AR | 100 | 363 of 377 |
LBR | Hydrops-Ectopic Calcification-Moth- Eaten Skeletal Dysplasia, Pelger-Huet Anomaly, Reynolds Syndrome, Greenberg Dysplasia, Reynolds Syndrome | AD,AR | 99.98 | 34 of 34 |
LGI1 | Epilepsy | AD | 99.94 | 54 of 54 |
LIAS | Pyruvate Dehydrogenase LipoicAcidSynthetase Deficiency | AR | 99.82 | 8 of 8 |
LMNB1 | Leukodystrophy | AD | 99.66 | 4 of 4 |
LMNB2 | Barraquer-Simons Syndrome, Epilepsy, Acquired Partial Lipodystrophy | AD,AR | 95.03 | 5 of 5 |
LNPK | Neurodevelopmental Disorder With Epilepsy And Hypoplasia Of The Corpus Callosum | AR | 99.26 | – |
LRPPRC | Leigh Syndrome | AR | 98.94 | 18 of 18 |
LYRM7 | Mitochondrial ComplexIii Deficiency | AR | 99.86 | 9 of 9 |
MACF1 | Lissencephaly | AD | 99.94 | 18 of 18 |
MAGI2 | Nephrotic Syndrome | AR | 93.82 | 7 of 9 |
MAP2K1 | Cardiofaciocutaneous Syndrome, Melorheostosis, Noonan Syndrome | AD | 100 | 31 of 31 |
MAP2K2 | Cardiofaciocutaneous Syndrome, Neurofibromatosis- Noonan Syndrome | AD | 100 | 37 of 37 |
MAPK10 | Lennox- GastautSyndrome | – | 99.97 | – |
MARCHF6 | Epilepsy | AD | 99.97 | – |
MARS2 | Ataxia, Oxidative Phosphorylation Deficiency, Spastic Ataxia With Leukoencephalopathy | AR | 99.94 | 3 of 3 |
MBD5 | 2q23.1 Microdeletion Syndrome | AD | 99.99 | 33 of 35 |
MBOAT7 | Mental Retardation | AR | 99.08 | 11 of 12 |
MCOLN1 | Mucolipidosis | AR | 99.99 | 34 of 36 |
MCPH1 | Microcephaly | AR | 99.51 | 18 of 19 |
MDH2 | EpilepticEncephalopathy, Pheochromocytoma- Paraganglioma | AR | 98 | 11 of 11 |
ME2 | Epilepsy, Li- FraumentiSyndrome | – | 99.99 | 1 of 1 |
MECP2 | Autism, Encephalopathy, Lubs Mental Retardation Syndrome, Rett Syndrome, Trisomy Xq28 | X,XR,XD,MU,G | 99.81 | – |
MED12 | Lujan-Fryns Syndrome, Ohdo Syndrome, Opitz- Kaveggia Syndrome, Blepharophimosis- Intellectual Disability Syndrome, Fg Syndrome | X,XR,G | 100 | – |
MED17 | Microcephaly | AR | 100 | 9 of 9 |
MEF2C | Mental Retardation, Stereotypic Movements, Epilepsy, Cerebralmalformations, 5q14.3 Microdeletion Syndrome | AD | 99.91 | 43 of 46 |
MFSD8 | CeroidLipofuscinosis, Macular Dystrophy | AR | 100 | 63 of 63 |
MGAT2 | CongenitalDisorder Of Glycosylation | AR | 97.19 | 5 of 5 |
MICAL1 | Epilepsy | AD | 99.98 | 3 of 3 |
MIPEP | CombinedOxidative Phosphorylation Deficiency | AR | 99.84 | 7 of 8 |
MLC1 | Megalencephalic Leukoencephalopathy | AR | 100 | 104 of 106 |
MOCS1 | Molybdenum Cofactor Deficiency | AR | 100 | 36 of 37 |
MOCS2 | Molybdenum Cofactor Deficiency | AR | 100 | 32 of 32 |
MOGS | CongenitalDisorder Of Glycosylation | AR | 100 | 10 of 10 |
MPDU1 | CongenitalDisorder Of Glycosylation | AR | 100 | 7 of 7 |
MRPL44 | Oxidative Phosphorylation Deficiency | AR | 99.75 | 2 of 2 |
MTFMT | Oxidative Phosphorylation Deficiency, Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy | AR | 99.52 | 18 of 18 |
MTHFR | Homocystinuria, Neural Tube Defects, Schizophrenia, Thrombophiliavenous Thromboembolism, Isolated Anencephaly , Isolated Exencephaly | AD,AR | 100 | 122 of 122 |
MTHFS | Neurodevelopmental Disorder With Microcephaly, Epilepsy, Hypomyelination | AR | 100 | 5 of 5 |
MTOR | Dysplasia Of Taylor, Smith-Kingsmore Syndrome, Macrocephaly- Intellectual Disability- Neurodevelopmental Disorder-Small Thorax Syndrome | AD | 99.98 | 39 of 39 |
NACC1 | Neurodevelopmental Disorder With Epilepsy, Cataracts, Feeding Difficulties, Delayed Brain Myelination | AD | 99.99 | 3 of 3 |
NAGLU | Charcot-Marie-Tooth Disease, Mucopoly saccharidosis | AD,AR | 93.23 | 194 of 222 |
NBEA | Autism, Oxidative Phosphorylation Deficiency | – | 99.48 | 27 of 27 |
NDE1 | Lissencephaly, Microhydranencephaly | AR | 86.55 | 12 of 13 |
NDST1 | Mental Retardation | AR | 99.99 | 11 of 11 |
NDUFA1 | MitochondrialComplex I Deficiency | X,XR,G | 100 | – |
NDUFA2 | Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy | AR | 99.84 | 2 of 3 |
NDUFAF3 | Mitochondrial Complex I Deficiency, Leigh Syndrome With Cardiomyopathy | AR | 100 | 9 of 9 |
NDUFAF5 | Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy | AR | 100 | 13 of 14 |
NDUFAF6 | Fanconi Renotubular Syndrome, Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy | AR | 99.4 | 12 of 13 |
NDUFS1 | Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy | AR | 99.98 | 30 of 30 |
NDUFS2 | Mitochondrial Complex I Deficiency, Leber Hereditary Optic Neuropathy, Leigh Syndrome With Cardiomyopathy, Leukodystrophy | AR | 100 | 26 of 26 |
NDUFS3 | Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy | AR | 93.67 | 4 of 4 |
NDUFS4 | Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy | AR,X,XD,MI,G | 100 | 15 of 15 |
NDUFS6 | MitochondrialComplex I Deficiency | AR | 100 | 6 of 6 |
NDUFS7 | Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy | AR | 88 | 6 of 7 |
NDUFS8 | Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy | AR | 100 | 16 of 16 |
NDUFV1 | Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy | AR | 100 | 36 of 36 |
NECAP1 | EpilepticEncephalopathy | AR | 99.83 | 2 of 2 |
NEDD4L | Periventricular Nodular Heterotopia | AD | 97.61 | 10 of 10 |
NEU1 | NeuraminidaseDeficiency, Sialidosis | AR | 100 | 68 of 68 |
NEUROD2 | Epileptic Encephalopathy | AD | 96.88 | 2 of 2 |
NEXMIF | Mental Retardation | X,XR,XD,G | 99.74 | – |
NF1 | JuvenileMyelomonocytic Leukemia, Neurofibromatosis- NoonanSyndrome, Watson Syndrome, 17q11.2 MicroduplicationSyndrome, Pheochromocytoma- Paraganglioma | AD | 97.97 | 3082 of 3166 |
NFU1 | MultipleMitochondrial Dysfunctions Syndrome | AR | 100 | 13 of 15 |
NGLY1 | Congenital Disorder Of Glycosylation, Alacrimia- Choreoathetosis- Liver Dysfunction Syndrome | AR | | 28 of 28 |
NHLRC1 | LaforaDisease | AR | 100 | 71 of 71 |
NIPBL | Cornelia De Lange Syndrome | AD | 99.32 | 409 of 426 |
NKX6-2 | Spastic Ataxia, Hypomyelinating Leukodystrophy | AR | 82.95 | 8 of 9 |
NOTCH3 | Cerebral Arteriopathy, Leukoencephalopathy, Lateral Meningocele Syndrome, Myofibromatosis, Myofibromatosis | AD | 96.31 | 398 of 399 |
NPC1 | Niemann-Pick Disease | AR | 97 | 503 of 505 |
NPC2 | Niemann-Pick Disease | AR | 100 | 27 of 27 |
NPHP1 | Joubert Syndrome, Nephronophthisis, Senior-Loken Syndrome, Bardet- Biedl Syndrome, Joubert Syndrome With Renal Defect | AR | 100 | 58 of 59 |
NPRL2 | Epilepsy | AD | 100 | 12 of 12 |
NPRL3 | Epilepsy | AD | 99.61 | 18 of 18 |
NR2F1 | Bosch-Boonstra Optic Atrophy Syndrome | AD | 89.78 | 26 of 31 |
NRXN1 | Pitt-Hopkins- LikeSyndrome | AR | 97.42 | 33 of 74 |
NSD1 | Sotos Syndrome, 5q35 Microduplication Syndrome, Weaver Syndrome | AD | 99.8 | 451 of 459 |
NT5C2 | SpasticParaplegia | AR | 97.89 | 6 of 7 |
NTNG1 | Atypical Rett Syndrome | – | 99.96 | 2 of 2 |
NTRK2 | Epileptic Encephalopathy, Obesity, Hyperphagia, Developmental Delay, West Syndrome | AD | 100 | 9 of 9 |
NUBPL | MitochondrialComplex I Deficiency | AR | 95.2 | 13 of 13 |
NUS1 | Congenital Disorder Of Glycosylation, Mental Retardation, Epileptic Encephalopathy | AD,AR | 99.62 | 22 of 23 |
OFD1 | Joubert Syndrome, Orofaciodigital Syndrome, Retinitis Pigmentosa, Simpson-Golabi-Behmel Syndrome, Primary Ciliary Dyskinesia | X,XR,XD,G | 98.09 | – |
OPHN1 | Mental Retardation, CerebellarHypoplasia, Distinctivefacial Appearance | X,XR,G | 100 | – |
P4HTM | Hypotonia, Hyperventilation, Impaired Intellectual Development, Dysautonomia, Epilepsy, Eye Abnormalities | AR | 92.81 | 5 of 5 |
PACS1 | Intellectual Disability- Craniofacial Dysmorphism- Cryptorchidism Syndrome | AD | 97.98 | 3 of 3 |
PACS2 | Epileptic Encephalopathy | AD | 99.52 | 3 of 3 |
PAFAH1B1 | 17p13.3 Microduplication Syndrome, Lissencephaly, Miller-Dieker Syndrome | AD | 99.95 | 90 of 92 |
PAK3 | Mental Retardation | X,XR,G | 99.96 | – |
PANK2 | Hypoprebetalipo proteinemia, Acanthocytosis, Retinitis Pigmentosa, Pallidal Degeneration, Neurodegeneration, Pantothenate Kinase- Associated Neurodegeneration | AR | 98.92 | 177 of 182 |
PARS2 | Epileptic Encephalopathy | AR | 100 | 7 of 7 |
PC | PyruvateCarboxylase Deficiency | AR | 100 | 48 of 48 |
PCDH19 | Epilepsy, DravetSyndrome | X,G | 99.99 | – |
PCNT | Microcephalic Osteodysplastic Primordial Dwarfism, Seckel Syndrome | AR | 99.92 | 103 of 105 |
PDHA1 | Pyruvate Decarboxylase Deficiency, Leigh Syndrome With Leukodystrophy | X,XD,G | 99.02 | – |
PDSS2 | Coenzyme Q10 Deficiency, Leigh Syndrome With Nephrotic Syndrome | AR | 99.99 | 6 of 6 |
PEX1 | Hearing Loss With Enamel Hypoplasia And Nail Defects, Peroxisome Biogenesis Disorder, Zellweger Syndrome, Refsum Disease, Neonatal Adrenoleukodystrophy | AR | 97.02 | 126 of 134 |
PEX10 | Zellweger Syndrome, Refsum Disease, Neonatal Adrenoleukodystrophy | AR | 99.76 | 29 of 32 |
PEX12 | Zellweger Syndrome, Refsum Disease, Neonatal Adrenoleukodystrophy | AR | 100 | 38 of 38 |
PEX14 | Refsum Disease, Neonatal Adrenoleukodystrophy, Zellweger Syndrome | AR | 100 | 4 of 4 |
PEX2 | Refsum Disease, Neonatal Adrenoleukodystrophy, Zellweger Syndrome | AR | 99.89 | 17 of 17 |
PEX26 | Refsum Disease, Neonatal Adrenoleukodystrophy, Zellweger Syndrome | AR | 100 | 29 of 29 |
PEX3 | Refsum Disease, Neonatal Adrenoleukodystrophy, Zellweger Syndrome | AR | 100 | 9 of 9 |
PEX5 | Adrenoleukodystrophy, Cerebrohepatorenal Syndrome, Rhizomelic Chondrodysplasia Punctata, Refsum Disease, ZellwegerSyndrome | AR | 100 | 12 of 12 |
PEX6 | HeimlerSyndrome, Spinocerebellar Ataxia- Blindness-Deafness Syndrome, Deafness- EnamelHypoplasia- NailDefectsSyndrome, RefsumDisease, Neonatal Adrenoleukodystrophy, ZellwegerSyndrome | AD,AR | 99.94 | 105 of 108 |
PEX7 | ZellwegerSyndrome, Rhizomelic Chondrodysplasia Punctata, RefsumDisease | AR | 99.21 | 47 of 53 |
PGK1 | Phosphoglycerate Kina se 1 Deficiency, Glycogen Storage Disease | X,XR,G | 100 | – |
PHACTR1 | Epileptic Encephalopathy, West Syndrome | AD | 99.89 | 5 of 5 |
PHF6 | Borjeson-Forssman- Lehmann Syndrome | X,XR,G | 99.93 | – |
PIGA | Paroxysmal Nocturnal Hemoglobinuria, West Syndrome | X,XR,G | 97.98 | – |
PIGB | Epileptic Encephalopathy | AR | 99.97 | 10 of 10 |
PIGC | Glycosyl phosphatidylinositol BiosynthesisDefect | AR | 99.59 | 4 of 4 |
PIGG | Epilepsy-Intellectual Disability-Brain Anomalies Syndrome | AR | 99.86 | 6 of 6 |
PIGN | Fryns Syndrome, Multiple Congenital Anomalies-Hypotonia- Seizures Syndrome | AR | 93.97 | 36 of 39 |
PIGO | Hyperphosphatasia With Mental Retardation Syndrome | AR | 99.93 | 21 of 21 |
PIGP | Epileptic Encephalopathy | AR | 99.98 | 2 of 2 |
PIGQ | Epileptic Encephalopathy | AR | 99.99 | 4 of 4 |
PIGS | Glycosylphos phatidylinositol Biosynthesis Defect | AR | 100 | 6 of 6 |
PIGT | Paroxysmal Nocturnal Hemoglobinuria, Intellectual Disability- Seizures- Hypophosphatasia- Ophthalmic-Skeletal Anomalies Syndrome | AD,AR | 100 | 15 of 15 |
PIGV | Hyperphosphatasia- Intellectual Disability Syndrome | AR | 99.99 | 16 of 16 |
PIGW | Hyperphosphatasia- IntellectualDisability Syndrome | AR | 99.52 | 6 of 6 |
PIK3AP1 | Bissinosis, Central Nervous System Tuberculosis | – | 99.98 | 5 of 5 |
PITRM1 | Alzheimer Disease, Berylliosis | – | 100 | 3 of 3 |
PLA2G6 | Neuroaxonal Dystrophy, Neurodegeneration With Brain Iron Accumulation, Parkinson Disease | AR | 99.94 | 190 of 191 |
PLAA | Neurodevelopmental Disorder, Microcephaly, Spasticity | AR | 99.41 | 6 of 6 |
PLCB1 | Epileptic Encephalopathy, West Syndrome | AR | 99.92 | 4 of 6 |
PLP1 | Pelizaeus- Merzbacher Disease, Spastic Paraplegia | X,XR,G | 100 | – |
PLPBP | Epilepsy | AR | 100 | – |
PMM2 | CongenitalDisorder Of Glycosylation | AR | 100 | 127 of 129 |
PMPCB | MultipleMitochondrial DysfunctionsSyndrome | AR | 99.46 | 5 of 5 |
PNKD | Paroxysmal Nonkinesigenic Dyskinesia | AD | 99.98 | 6 of 6 |
PNKP | Ataxia-Oculomotor Apraxia, Charcot- Marie-Tooth Disease, Epileptic Encephalopathy | AR | 100 | 36 of 36 |
PNPO | Pyridoxamine 5-Prime- Phosphate Oxidase Deficiency, Pyridoxal Phosphate- Responsive Seizures | AR | 99.99 | 31 of 31 |
POLG | MitochondrialDna DepletionSyndrome, External Ophthalmoplegia WithMitochondrial DnaDeletions, SensoryAtaxic Neuropathy, Dysarthria, Ophthalmoparesis, Alpers-Huttenlocher Syndrome, Mitochondrial Neurogastrointestinal Encephalomyopathy | AD,AR | 99.92 | 325 of 326 |
POLR3A | Leukodystrophy, Progeroid Syndrome, Tremor-Ataxia-Central Hypomyelination Syndrome, Wiedemann- Rautenstrauch Syndrome | AR | 100 | 122 of 122 |
POLR3B | Leukodystrophy, Hypomyelination- Hypogonadotropic Hypogonadism- Hypodontia Syndrome | AR | 100 | 61 of 61 |
POMGNT1 | Muscular Dystrophy- Dystroglycanopathy, Retinitis Pigmentosa, Muscle-Eye-Brain Disease, Walker- Warburg Syndrome | AR | 99.91 | 82 of 83 |
POMT1 | Limb-Girdle Muscular Dystrophy- Dystroglycanopathy, Muscle-Eye-Brain Disease, Walker- Warburg Syndrome | AR | 100 | 105 of 105 |
POMT2 | Limb-Girdle Muscular Dystrophy- Dystroglycanopathy, Muscle-Eye-Brain Disease, Walker- Warburg Syndrome | AR | | 74 of 74 |
PPP2CA | Neurodevelopmental Disorder And Language Delay | AD | 99.9 | 14 of 14 |
PPP3CA | Arthrogryposis, Cleft Palate, Craniosynostosis, Impaired Intellectual Development, Epileptic Encephalopathy | AD | 99.98 | 16 of 16 |
PPT1 | Ceroid Lipofuscinosis | AR | 100 | 81 of 81 |
PQBP1 | Renpenning Syndrome, Hamel Cerebro -Palato-Cardiac Syndrome | X,XR,G | 99.99 | – |
PRDM8 | Epilepsy, LaforaBody Disease | AR | 89.24 | 1 of 1 |
PRICKLE1 | Epilepsy, Unverricht- LundborgDisease | AR | 98.41 | 23 of 23 |
PRICKLE2 | Epilepsy | – | 94.92 | 6 of 6 |
PRIMA1 | MiocardialInfarction, Ichthyosis | – | 99.59 | 1 of 1 |
PRODH | Hyperprolinemia, Schizophrenia | AD,AR | 98.57 | 5 of 5 |
PRRT2 | Convulsions, Dyskinesia, Epilepsy, Hemiplegic Migraine | AD | 99.93 | 111 of 111 |
PSAP | Saposin Deficiency, Gaucher Disease, Krabbe Disease, Metachromatic Leukodystrophy, Encephalopathy | AR | 100 | 33 of 33 |
PTCH1 | Basal Cell Carcinoma, Basal Cell Nevus Syndrome, Holoprosencephaly, Gorlin Syndrome, Monosomy 9q22.3 | AD | 98.89 | 498 of 502 |
PTEN | Cowden Disease, Autism, Meningioma, Bannayan-Riley- Ruvalcaba Syndrome, Juvenile Polyposis Of Infancy, Lhermitte- Duclos Disease, Proteus Syndrome, Segmental Outgrowth- Lipomatosis- Arteriovenous Malformation- Epidermal Nevus Syndrome | AD | 99.97 | 609 of 629 |
PTPN11 | Myelomonocytic Leukemia, LeopardSyndrome, Metachondromatosis NoonanSyndrome | AD | 100 | 150 of 151 |
PTPN23 | Neurodevelopmental Disorder And Structural Brain Anomalies | AR | 99.99 | 17 of 17 |
PTS | 6-Pyruvoyl- Tetrahydropterin SynthaseDeficiency | AR | 99.97 | 108 of 112 |
PUM1 | Spinocerebellar Ataxia | AD | 99.98 | 8 of 8 |
PURA | Mental Retardation | AD | 85.36 | 59 of 65 |
PYCR2 | Leukodystrophy, Leukoence phalopathy | AR | 98.29 | 14 of 14 |
QARS | Microcephaly | – | 100 | 12 of 12 |
QDPR | Phenylketonuria, Dihydropteridine Reductase Deficiency | AR | 100 | 66 of 67 |
RAB39B | Mental Retardation, Parkinsonism | X,XR,G | 100 | – |
RAB3GAP1 | Warburg Micro Syndrome, Cataract- Intellectual Disability- Hypogonadism Syndrome | AR | 99.94 | 70 of 70 |
RAI1 | Smith-Magenis Syndrome, 17p11.2 Microduplication Syndrome, Gene Duplication Syndrome | AD | 99.91 | 50 of 53 |
RALA | Tuberculosos, MyocardialInfarction | – | 99.94 | 7 of 7 |
RANBP2 | Necrotizing Encephalopathy | AD | 99.41 | 9 of 9 |
RARS1 | Leukodystrophy | AR | 99.64 | 28 of 28 |
RARS2 | Pontocerebellar Hypoplasia | AR | 99.98 | 39 of 40 |
RBFOX1 | Epilepsy, Spinocerebellar Ataxia, Developmental Coordination Disorder | – | 97.99 | 4 of 5 |
RBFOX3 | Epilepsy, EctodermalDysplasia | – | 88.9 | 1 of 1 |
RELN | Epilepsy, Lissencephaly | AD,AR | 100 | 70 of 70 |
RFT1 | CongenitalDisorder Of Glycosylation | AR | 99.98 | 18 of 18 |
RHOBTB2 | Epileptic Encephalopathy | AD | 100 | 6 of 6 |
RMND1 | CombinedOxidative Phosphorylation Deficiency | AR | 99.67 | 15 of 16 |
RNASEH2A | Aicardi-Goutieres Syndrome | AR | 100 | 23 of 23 |
RNASEH2B | Aicardi-Goutieres Syndrome | AR | 99.95 | 41 of 41 |
RNASEH2C | Aicardi-Goutieres Syndrome | AR | 100 | 14 of 14 |
RNASET2 | Leukoencephalopathy | AR | 100 | 11 of 13 |
RNF13 | Epileptic Encephalopathy | AD | 99.88 | 2 of 2 |
RNF216 | Cerebellar Ataxia- Hypogonadism Syndrome | AR | 99.89 | 15 of 15 |
RNR1 | MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres) | – | – | – |
ROGDI | Kohlschutter-Tonz Syndrome, Amelocere brohypohidrotic Syndrome | AR | 99.83 | 10 of 12 |
RORA | Intellectual Developmental Disorder, Epilepsy, Cerebellar Ataxia | AD | 99.94 | 12 of 12 |
RORB | Epilepsy | AD | 99.98 | 4 of 4 |
RPGRIP1L | Coach Syndrome, Joubert Syndrome, Meckel Syndrome, Joubert Syndrome | AR | 99.96 | 52 of 52 |
RUBCN | Spinocerebellar And Cerebellar Ataxia | AR | 99.96 | – |
RYR3 | Deafness | – | 99.98 | 20 of 20 |
SAMD12 | Epilepsy | AD | 99.74 | – |
SAMHD1 | Aicardi-Goutieres Syndrome | AD,AR | 100 | 51 of 51 |
SATB2 | Chromosome 2q32- Q33 Deletion Syndrome | AD | 99.87 | 97 of 124 |
SCARB2 | Action Myoclonus- Renal Failure Syndrome, Gaucher Disease, Unverricht-Lundborg Disease | AR | 99.95 | 29 of 29 |
SCN10A | Episodic Pain Syndrome, Brugada Syndrome, Paroxysmal Extreme Pain Disorder, Primary Erythromelalgia, Romano-Ward Syndrome | AD | 99.89 | 96 of 96 |
SCN1A | Epileptic Encephalopathy, Febrile Convulsions, Migraine, Dravet Syndrome, Lennox-Gastaut Syndrome | AD | 99.8 | 1776 of 1797 |
SCN1B | Atrial Fibrillation, Brugada Syndrome, Epileptic Encephalopathy, Dravet Syndrome, Familial Progressive Cardiac Conduction Defect | AD,AR | 99.67 | 46 of 48 |
SCN2A | Epileptic Encephalopathy, Episodic Ataxia, Seizures , Dravet Syndrome, West Syndrome | AD | 100 | 351 of 351 |
SCN3A | Epileptic Encephalopathy | AD | 99.98 | 18 of 18 |
SCN4A | Hyperkalemic Periodic Paralysis, Myasthenic Syndrome, Myotonia, Paramyotonia Congenita Of Von Eulenburg, Postsynaptic Congenital Myasthenic Syndromes | AD,AR | 99.77 | 136 of 142 |
SCN5A | Atrial Fibrillation, Brugada Syndrome, Cardiomyopathy, Long Qt Syndrome, Heart Block, Sick Sinus Syndrome, Sudden Infant Death Syndrome, Romano-Ward Syndrome | AD,AR,MU | 99.45 | 929 of 942 |
SCN8A | Cognitive Impairment With Or Without Cerebellar Ataxia, Epileptic Encephalopathy, Myoclonus, Seizures, Infantile Convulsions And Choreoathetosis | AD | 97.85 | 156 of 172 |
SCN9A | Erythermalgia, Epilepsy, Indifference To Pain, Neuropathy, Extreme Pain Disorder, Dravet Syndrome, Primary Erythromelalgia | AD,AR | 96.25 | 126 of 137 |
SCO1 | ComplexIv Deficiency | AR,MI | 100 | 6 of 6 |
SCO2 | Cardioence phalomyopathy, Myopia, Charcot-Marie- Tooth Disease, Leigh Syndrome With Cardiomyopathy | AD,AR | 100 | 38 of 38 |
SDHA | Cardiomyopathy, Leigh Syndrome, Paragangliomas, Pheochromocytoma- Paraganglioma, Succinate-Coq Reductase Deficiency | AD,AR,MI | 99.98 | 103 of 103 |
SDHAF1 | Succinate-Coq Reductase Deficiency | AR | 100 | 6 of 6 |
SERAC1 | Methylglutaconic Aciduria, Deafness, Encephalopathy, Leigh-Like Syndrome | AR | 99.93 | 53 of 53 |
SERPINI1 | Encephalopathy | AD | 100 | 9 of 9 |
SETBP1 | Mental Retardation, Schinzel-Giedion Midface-Retraction Syndrome, Intellectual Disability-Expressive Aphasia-Facial Dysmorphism Syndrome | AD | 98.61 | 43 of 43 |
SETD2 | Luscan-Lumish Syndrome, Sotos Syndrome | AD | 99.83 | 19 of 19 |
SGCE | MyoclonicDystonia | AD | 99.46 | 94 of 98 |
SGSH | Mucopolysaccharidosis | AR | 97.7 | 151 of 151 |
SHH | Holoprosencephaly, Microphthalmia, Schizencephaly, HypoplasticTibiae- PostaxialPolydactyly Syndrome, Radial Hemimelia, Syndactyly | AD | 99.48 | 161 of 184 |
SHOC2 | NoonanSyndrome | AD | 99.98 | 8 of 8 |
SIK1 | Myoclonic And Epileptic Encephalopathy, West Syndrome | AD | 99.67 | 9 of 9 |
SIX3 | Holoprosencephaly, Schizencephaly | AD | 99.79 | 79 of 80 |
SLC12A5 | Epileptic Encephalopathy | AD,AR | 100 | 19 of 19 |
SLC13A5 | EpilepticEnce phalopathy, Amelocerebrohy pohidrotic Syndrome | AR | 95.92 | 24 of 24 |
SLC17A5 | Infantile Sialic Acid Storage Disorder, Sialuria | AR | 99.91 | 49 of 49 |
SLC19A3 | Basal Ganglia Disease, Leigh Syndrome, Leukodystrophy | AR | 100 | 38 of 39 |
SLC1A2 | Epileptic Encephalopathy | AD | 100 | 7 of 7 |
SLC1A3 | Episodic Ataxia | AD | 100 | 13 of 13 |
SLC1A4 | SpasticTetraplegia, Microcephaly | AR | 99.76 | 8 of 9 |
SLC25A1 | D-2- And L-2- Hydroxyglutaric Aciduria, Myasthenic Syndrome | AR | 90 | 23 of 25 |
SLC25A12 | Epileptic Encephalopathy | AR | 100 | 7 of 7 |
SLC25A15 | Hyperornithinemia- Hyperammonemia- Homocitrullinuria Syndrome | AR | 100 | 41 of 41 |
SLC25A19 | Microcephaly, Thiamine Metabolism Dysfunction Syndrome | AR | 97.13 | 10 of 10 |
SLC25A22 | Epileptic Encephalopathy, Myoclonic Encephalopathy | AR | 100 | 16 of 16 |
SLC25A42 | Metabolic Crises, Encephalomyopathy | AR | 99.91 | 2 of 2 |
SLC2A1 | Choreoathetosis, Epilepsy, Glucose Transport Defect, Stomatin-Deficient Cryohydrocytosis | AD,AR | 99.99 | 301 of 304 |
SLC35A1 | CongenitalDisorder Of Glycosylation | AR | 100 | 6 of 6 |
SLC35A2 | CongenitalDisorder Of Glycosylation | X,XD,G | 99.97 | – |
SLC35A3 | Arthrogryposis, Autism Spectrum Disorder-Epilepsy- Arthrogryposis Syndrome | AR | 99.94 | 5 of 5 |
SLC35C1 | CongenitalDisorder Of Glycosylation | AR | 99.73 | 8 of 8 |
SLC39A8 | CongenitalDisorder Of Glycosylation | AR | 99.89 | 7 of 7 |
SLC46A1 | FolateMalabsorption | AR | 99.8 | 21 of 21 |
SLC4A10 | Epilepsy, Corneal Dystrophy | – | 99.94 | 4 of 4 |
SLC6A1 | Myoclonic- AstasticEpilepsy | AD | 100 | 55 of 55 |
SLC6A5 | Hyperekplexia | AD,AR | 100 | 37 of 37 |
SLC6A8 | CreatineDeficiency Syndrome | X,XR,G | 99.87 | – |
SLC6A9 | Glycine Encephalopathy | AR | 99.99 | 5 of 5 |
SLC9A6 | Christianson Syndrome | X,XD,G | 98.87 | – |
SMARCA2 | Nicolaides-Baraitser Syndrome, Intellectual Disability-Sparse Hair-Brachydactyly Syndrome | AD | 97.99 | 80 of 81 |
SMC1A | Cornelia De Lange Syndrome, Semilobar Holoprosencephaly, Wiedemann-Steiner Syndrome | X,XR,XD,G | 100 | – |
SMC3 | Cornelia De Lange Syndrome | AD | 100 | 30 of 30 |
SMS | Mental Retardation | X,XR,G | 84.04 | – |
SNAP25 | Myasthenic Syndrome | AD | 100 | 6 of 6 |
SNIP1 | Psychomotor Retardation, Craniofacial Dysmorphism
| AR | 99.68 | 1 of 1 |
SNORD118 | Leukoencephalopathy | AR | – | – |
SNX27 | Epilepsy, Parkinson Disease | – | 99.52 | 1 of 1 |
SOX10 | Waardenburg Syndrome, KallmannSyndrome | AD | 99.74 | 139 of 147 |
SPATA5 | Epilepsy, Deafness | AR | 99.83 | 30 of 30 |
SPR | Dystonia, Sepiapterin Reductase Deficiency | AD,AR | 99.89 | 27 of 27 |
SPRED1 | LegiusSyndrome | AD | 100 | 84 of 84 |
SPTAN1 | Epileptic Encephalopathy, West Syndrome | AD | 100 | 52 of 53 |
SPTBN4 | Myopathy, Deafness | AR | 99.26 | 10 of 10 |
SRGAP2 | Epileptic Encephalopathy, Pilocytic Astrocytoma, West Syndrome, Chromosome 3pter-P25 Deletion Syndrome | – | 96.8 | 1 of 1 |
SRPX2 | Rolandic Epilepsy, Speech Dyspraxia , Bilateral Perisylvian Polymicrogyria | AD | 100 | – |
ST3GAL3 | Epileptic Encephalopathy, Mental Retardation, West Syndrome | AR | 100 | 5 of 5 |
ST3GAL5 | EpilepsySyndrome | AR | 99.17 | 6 of 6 |
STAG1 | Mental Retardation, Facial Dysmorphism , Gastroesophageal Reflux | AD | 99.98 | 16 of 22 |
STARD7 | Epilepsy | AD | 98.13 | 1 of 1 |
STIL | Microcephaly | AR | 99.94 | 18 of 18 |
STRADA | Polyhydramnios, Megalencephaly, Epilepsy | AR | 97.95 | 4 of 6 |
STX1B | GeneralizedEpilepsy, FebrileSeizures | AD | 100 | 24 of 24 |
STXBP1 | Epileptic Encephalopathy, 9q33.3q34.11 Microdeletion Syndrome, Rett Syndrome, Dravet Syndrome, West Syndrome | AD | 100 | 209 of 215 |
SUMF1 | Multiple Sulfatase Deficiency | AR | 100 | 52 of 52 |
SUOX | Sulfocysteinuria | AR | 99.98 | 28 of 28 |
SURF1 | Charcot-Marie- Tooth Disease, Leigh Syndrome, Leukodystrophy | AR,MI | 98.59 | 117 of 124 |
SYN1 | Epilepsy, LearningDisabilities | X,XR,XD,G | 91.7 | – |
SYNGAP1 | Mental Retardation, EpilepticEncephalopathy | AD | 99.46 | 168 of 171 |
SYNJ1 | EpilepticEncephalopathy, Parkinson Disease | AR | 99.81 | 30 of 32 |
SYP | Mental Retardation | X,XR,G | 99.98 | – |
SZT2 | EpilepticEncephalopathy | AR | 99.98 | 39 of 39 |
TACO1 | Mitochondrial Complex Iv Deficiency, Leigh Syndrome, Leukodystrophy | AR,MI | 100 | 3 of 3 |
TAF1 | Dystonia, Mental Retardation, Parkinsonism | X,XR,G | 99.74 | – |
TBC1D20 | Warburg Micro Syndrome | AR | 99.94 | 6 of 6 |
TBC1D24 | Deafness, Doors Syndrome, Epileptic Encephalopathy, Myoclonic Epilepsy, Dystonia | AD,AR | 100 | 80 of 80 |
TBCD | Encephalopathy, Diffuse Brain Atrophy, Microcephaly | AR | 94.89 | 28 of 28 |
TBCE | Epileptic Encephalopathy, Hypoparathyroidism- Retardation- Dysmorphism Syndrome, Kenny-Caffey Syndrome, Spastic Ataxia, Sanjad- Sakati Syndrome | AR | 100 | 8 of 8 |
TBCK | Hypotonia, Intellectual Disability | AR | 99.95 | 15 of 15 |
TBL1XR1 | Mental Retardation, Pierpont Syndrome, PromyelocyticLeukemia | AD | 99.78 | 23 of 23 |
TBX1 | Conotruncal Heart Malformations, Digeorge Syndrome , Tetralogy Of Fallot, Velocardiofacial Syndrome, 22q11.2 Deletion Syndrome, 22q11.2 Microduplication Syndrome | AD,AR | 88.7 | 35 of 42 |
TCF4 | Corneal Dystrophy, Pitt-Hopkins Syndrome, Sclerosing Cholangitis | AD | 98.91 | 124 of 124 |
TDP2 | Spinocerebellar Ataxia | AR | 99.93 | 8 of 8 |
TIMM50 | 3-Methylglutaconic Aciduria | AR | 91 | 7 of 7 |
TMEM67 | Bardet-Biedl Syndrome, Coach Syndrome, Joubert Syndrome, Meckel Syndrome, Nephronophthisis, Rhyns Syndrome | AR | 96.93 | 177 of 179 |
TMEM70 | MitochondrialComplex V Deficiency, Encephalo- Cardiomyopathy | AR | 100 | 22 of 24 |
TNK2 | Gastric Adenocarcinoma, Epilepsy | – | 99.72 | 6 of 7 |
TPK1 | ThiamineMetabolism Dysfunction Syndrome | AR | 99.81 | 15 of 15 |
TPP1 | CeroidLipofuscinosis, Spinocerebellar Ataxia | AR | 100 | 147 of 147 |
TRAK1 | EpilepticEncephalopathy | AR | 99.28 | 7 of 7 |
TRAPPC6B | Neurodevelopmental Disorder, Microcephaly, Epilepsy, Brain Atrophy | AR | 100 | 4 of 4 |
TREX1 | Aicardi-GoutieresSyndrome, Chilblain Lupus, Systemic Lupus Erythematosus, Vasculopathy, Cerebral Leukodystrophy | AD,AR | 100 | 75 of 75 |
TRIM8 | EpilepticEncephalopathy | – | 99.5 | 7 of 7 |
TRNF | Mitochondrial Myopathy, Epileptic Encephalopathy, MELAS (Myoclonic Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes), MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres) | MI | – | – |
TRNH | MELAS (Myoclonic Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes), MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres) | – | – | – |
TRNI | MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres) | MI | – | – |
TRNK | MELAS (Myoclonic Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes), MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres), Leigh Syndrome, Cardiomyopathy, Deafness | MI | – | – |
TRNL1 | MELAS (Myoclonic Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes), MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres), Kearns- Sayre Syndrome, Deafness, Leigh Syndrome, Ophthalmoplegia | MI | – | – |
TRNP | MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres) | MI | – | – |
TRNQ | MELAS (Myoclonic Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes), MERRF (Myoclonus Epilepsy Associated With Ragged- Red Fibres) | MI | – | – |
TRNS1 | Mitochondrial Complex Iv Deficiency, MELAS (Myoclonic Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes), MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres), Ophthalmoplegia, Palmoplantar Keratoderma- Deafness Syndrome | AR,MI | – | – |
TRNS2 | MELAS (Myoclonic Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes), MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres), Usher Syndrome | MI | – | – |
TSC1 | Dysplasia Of Taylor, Lymphangioleiomyomatosis, Tuberous Sclerosis | AD | 99.86 | 390 of 406 |
TSC2 | Dysplasia Of Taylor, Lymphangioleiomyomatosis, Tuberous Sclerosis | AD | 100 | 1157 of 1159 |
TSEN2 | Pontocerebellar Hypoplasia | AR | 95.47 | 4 of 5 |
TSEN34 | Pontocerebellar Hypoplasia | AR | 100 | 1 of 1 |
TSEN54 | Encephalopathy, Olivopontocerebellar Hypoplasia | AR | 96.94 | 20 of 22 |
TTC19 | Mitochondrial ComplexIii Deficiency | AR | 95.3 | 10 of 12 |
TUBA1A | Lissencephaly | AD | 100 | 95 of 95 |
TUBA8 | Polymicrogyria With Optic Nerve Hypoplasia | AR | 80.97 | 5 of 5 |
TUBB2A | Cortical Dysplasia | AD | 81.71 | 5 of 7 |
TUBB2B | Cortical Dysplasia, Dysequilibrium Syndrome, Polymicrogyria | AD | 84.28 | 29 of 38 |
TUBB4A | Dystonia, Leukodystrophy | AD | 89.81 | 44 of 44 |
TWNK | Spinocerebellar Ataxia, Perrault Syndrome , Ophthalmoplegia, Dysarthria | AD,AR | – | – |
UBA5 | Epileptic Encephalopathy, Spinocerebellar Ataxia | AR | 99.98 | 19 of 19 |
UBE2A | Mental Retardation | X,XR,G | 99.99 | – |
UBE3A | Angelman Syndrome, 15q11q13 Microduplication Syndrome | AD | 99.98 | 208 of 211 |
UNC80 | Hypotonia, SpeechImpairment | AR | 99.95 | 39 of 39 |
VAMP2 | Neurodevelopmental Disorder, Hypotonia, Hyperkinetic Movements | AD | 99.62 | 5 of 5 |
VARS1 | Neurodevelopmental Disorder, Microcephaly, Cortical Atrophy | AR | 97.86 | 19 of 20 |
VPS13A | Choreoacanthocytosis | AR | 99.37 | 120 of 122 |
VPS13B | Cohen Syndrome | AR | 99.98 | 182 of 190 |
WARS2 | Neurodevelopmental Disorder, Lactic Acidosis, Oxidative Phosphorylation Defect | AR | 99.95 | 14 of 15 |
WASF1 | Neurodevelopmental Disorder, Seizures | AD | 97.03 | 3 of 3 |
WDR26 | Skraban-Deardorff Syndrome, Intellectual Disability, Seizures, Facial Dysmorphism | AD | 99.31 | 22 of 22 |
WDR45 | Neurodegeneration, Brain Iron Accumulation, West Syndrome | X,XD,G | 100 | – |
WWOX | Epileptic Encephalopathy, Esophageal Cancer, Spinocerebellar Ataxia, Gonadal Dysgenesis, Squamous Cell Carcinoma Of The Esophagus | AR | 99.94 | 44 of 44 |
YEATS2 | MyoclonicEpilepsy | AD | 99.98 | 1 of 1 |
YWHAG | Epileptic Encephalopathy | AD | 99.94 | 5 of 5 |
ZDHHC9 | Mental Retardation | X,G | 100 | – |
ZEB2 | Mowat-Wilson Syndrome | AD | 98.95 | 253 of 254 |
ZFYVE26 | SpasticParaplegia | AR | 99.95 | 48 of 48 |
ZIC2 | Holoprosencephaly | AD | 84.47 | 86 of 112 |